Lupron vs Eligard, Trelstar and Others | скачать в хорошем качестве

Lupron vs Eligard, Trelstar and Others |

Donate to PCRI: https://pcri.org/donate For more information. visit www.pcri.org 0:35 What are the First-Generation Hormone Therapies, and how do they compare to one another? 2:39 Are there any drugs in this category that are especially prone to side effects? 4:34 Before treatment should patients get their testosterone checked? 5:18 Is the timing of PSA response similar across all of the drugs in this category? 5:38 Is there ever a need for a patient to switch from one hormone therapy to another? 6:06 Which of the First-Generation Hormone Therapies are the most affordable? 6:29 Can those with pre-existing conditions use hormone therapies? 7:41 How is weight gain managed for patients on hormone therapy? 8:36 Are there any First-Generation Hormone Therapies that cause excess fatigue? 9:35 Is hormone therapy use associated with Alzheimers Disease? 11:55 Alex's conclusion Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org To learn more about prostate cancer, visit http://www.pcri.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.